CPBTD
HAE icon

Central Pacific Bank - Trust Division’s Haemonetics HAE Stock Holding History

Central Pacific Bank - Trust Division’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$308K Sell
2,926
-2,480
-46% -$231K 0.03% 373
2026
Q2 		$405K Sell
5,406
-35
-0.6% -$2.25K 0.04% 349
2026
Q1 		$307K Sell
5,441
-3,459
-39% -$225K 0.04% 370
2025
Q4 		$713K Buy
8,900
+188
+2% +$12.6K 0.09% 240
2025
Q3 		$425K Buy
8,712
+1,089
+14% +$67.4K 0.05% 312
2025
Q2 		$569K Buy
7,623
+2,988
+64% +$198K 0.07% 263
2025
Q1 		$295K Buy
4,635
+2,170
+88% +$148K 0.04% 361
2024
Q4 		$192K Sell
2,465
-300
-11% -$24.1K 0.03% 456
2024
Q3 		$222K Buy
2,765
+656
+31% +$53K 0.03% 439
2024
Q2 		$174K Buy
2,109
+468
+29% +$41.2K 0.02% 578
2024
Q1 		$139K Buy
+1,641
New +$129K 0.02% 612

Other funds holding HAE

CIM
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Central Pacific Bank - Trust Division's HAE Position: Q3 2026 in Review

Central Pacific Bank - Trust Division reduced its Haemonetics (HAE) stake by 46% in Q3 2026, selling an estimated $231K and leaving 2,926 shares worth $308K. The position accounts for 0.03% of the portfolio, ranked #373.

Central Pacific Bank - Trust Division first reported a position in HAE in Q1 2024 and has held it in 11 quarters since. The position peaked at $713K in Q4 2025. 7 funds tracked by Wall St. Rank hold HAE as of Q3 2026.

  • Central Pacific Bank - Trust Division held 2,926 shares of Haemonetics worth $308K as of Q3 2026.
  • Central Pacific Bank - Trust Division sold 2,480 Haemonetics shares in Q3 2026, an estimated $231K.
  • Haemonetics made up 0.03% of Central Pacific Bank - Trust Division's portfolio in Q3 2026, its #373 holding.
  • Central Pacific Bank - Trust Division first reported a position in Haemonetics in Q1 2024 and has held it in 11 quarters since.
  • Central Pacific Bank - Trust Division's Haemonetics position peaked at $713K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Haemonetics as of Q3 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q3 2026, filed 6 Oct 2026.